Importation
March Drug Importation Madness
For a pretty dead policy idea, bulk drug importation has had a lot of news lately. Get the update!
[...]PSM gives testimony in opposition to a Colorado bill to permit alternative funding programs
On February 17, PSM submitted written and oral testimony in opposition to Colorado HB26-1056, which would permit self-insured employers to use alternative funding programs to import foreign medicines from outside the U.S. drug supply chain.
[...]FDA announces changes to section 804 importation program proposals
A July 1, 2025 post clarifies that applicants can use “a static baseline approach for the cost-savings analysis” instead of trying to account for changes in unpredictable markets.
[...]PSM Testimony: NY state bill AB 7954 (Wholesale Canadian drug importation)
PSM submitted a letter to leaders in the New York State legislature opposing a legislative proposal (AB 7954) to setup a wholesale Canadian drug importation program. The bill died right before end of session.
[...]Colorado’s Canadian Rx import plan fuels counterfeit Ozempic dangers
Executive Director Shabbir Safdar’s editorial ran on May 15, 2024 in Colorado Politics
[...]Colorado updates drug importation proposal, cuts list of meds by 88, adds Ozempic
Colorado’s updated Canadian drug importation application to the FDA cuts the drug list from 112 to 24 and adds Ozempic to the list of medicines it wants from Canadians.
[...]PSM applauds NNOAC statement of concern about Canadian drug importation
“We are deeply concerned about the impact importation of unapproved foreign prescription drugs will have on counterfeit medication in the United States, especially as FDA considers approving additional SIPs.”
[...]Has any state tried Canadian drug importation? How did it work for them?
The state of Maine opened it’s border to Canadian drug importation program for Maine residents. Dr. Kenneth McCall purchased and tested some of the medicines being advertised and sold to Maine residents and found them lacking in safety. Listen to his story.
[...]The threat and enforcement challenges of counterfeit medicines
PSM’s Shabbir Imber Safdar sat down with three law enforcement experts about the problems they are seeing with counterfeit medicine. Watch here.
[...]Are Canadian patients struggling with drug shortages already?
PSM’s Shabbir Imber Safdar speaks to Canadian patient advocate Durhane Wong-Rieger about the drug shortage situation in Canada.
[...]